Life-extending breast cancer drug Enhertu approved for use on NHS in England
The medicine, which studies show can give patients an extra seven months to live on average, has been available in Scotland for more than two years
A drug that can extend the lives of some breast cancer patients has been approved for use on the NHS in England, according to the BBC.
The medicine, Enhertu, has been shown in clinical studies to give patients an extra seven months to live on average, the BBC reported.
According to the report, the drug has already been prescribed to patients in Scotland for more than two years, where it has been available through the NHS there.
The approval marks a significant step for eligible breast cancer patients in England who will now have access to the treatment through the NHS, the BBC said.
Further details on the specific eligibility criteria for patients and the timeline for the drug's rollout across England were not immediately available.
Sources
EGazette summarizes reporting from multiple sources; follow the links for the originals.
Related articles
NHS Patients With Incurable Breast Cancer to Get Life-Extending Drug After Reversal
A health body's decision to make the treatment available on the NHS in England comes two years after it was initially rejected as too costly.
Twenty women had breasts removed unnecessarily during NHS cancer care, trust says
County Durham and Darlington NHS Foundation Trust says the women were among hundreds of patients harmed at its breast unit
Thousands of Eligible Families Missing Out on NHS Food Support, Figures Show
New data cited by the BBC indicates that as few as 64% of families entitled to NHS money for milk, fruit and vegetables are actually claiming it.
Women Say They Suffered Unnecessary Mastectomies at County Durham Health Trust
BBC report highlights accounts from women who say they were harmed by treatment at a County Durham health trust, including one who underwent a mastectomy she says was not needed.
Former Cancer Chief Urges Burnham to Back 18-Week Dementia Diagnosis Target
England's former national cancer director has called for a referral-to-treatment waiting time target for dementia, according to a BBC Politics report.
Alibaba Open-Sources AI Model for Detecting Cancer and Other Medical Conditions
The Chinese technology company said the model can analyze contrast-enhanced CT scans of 18 abdominal organs to identify a range of diseases, including malignant tumors.
Comments
Loading comments…